Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or ...

Medtronic in Santa Ana says its layoffs are temporary while it repairs a roof, while Avante in San Clemente wades through ...

Medtronic (MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of ...

Medtronic announced results from a survey indicating that AI and VR could help reduce disparities in access to surgical ...

Analyst Nico Chen of DBS maintained a Hold rating on Medtronic (MDT – Research Report), retaining the price target of $90.00. Nico Chen ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Medtronic (NYSE:MDT – Free Report) had its price target increased by Truist Financial from $90.00 to $93.00 in a report issued on Monday, Benzinga reports. The firm currently has a hold rating on the ...

The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in patients with ventricular tachycardia, an abnormal heart rhythm.

Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

Medtronic has been notifying users of its MiniMed insulin pumps to be aware of potentially shortened battery lives, and to ...

Wedmont Private Capital raised its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 10.5% in the third quarter ...